Human ochratoxin A biomarkers-from exposure to effect

Critical Reviews in Toxicology

Volumn 41, Issue 3, 2011, Pages 187-212

  Duarte, Sofia Cancela ^a   Pena, Angelina ^a   Lino, Celeste Matos ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

2 microglobulin; Assessment; biomarker; biomonitoring; blood; DNA adducts; effect; exposure; milk; ochratoxin A; urine

Indexed keywords

BIOLOGICAL MARKER; MITOGEN ACTIVATED PROTEIN KINASE; OCHRATOXIN;

AGE; BIOLOGICAL MONITORING; BLOOD LEVEL; DNA ADDUCT; ENVIRONMENTAL EXPOSURE; GENDER; GEOGRAPHIC DISTRIBUTION; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; METABOLITE; MILK LEVEL; NEPHROTOXICITY; REVIEW; SEASONAL VARIATION; URINARY EXCRETION; URINE LEVEL;

BIOLOGICAL MARKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL EXPOSURE; HUMANS; OCHRATOXINS; POISONS;

EID: 79952615143     PISSN: 10408444     EISSN: 15476898     Source Type: Journal    
DOI: 10.3109/10408444.2010.529103     Document Type: Review

References (160)

1. Abid S, Hassen W, Achour A, Skhiri H, Maarouf K, Ellouz F, Creppy E, Bacha H. (2003). Ochratoxin A and human chronic nephropathy in Tunisia: Is the situation endemic? Hum Exp Toxicol 22:77-84. (Pubitemid 36410706)
2. Abouzied MM, Horvath AD, Podlesny PM, Regina NP, Metodiev VD, Kamenova-Tozeva RM, Niagolova ND, Stein AD, Petropoulos EA, Ganev VS. (2002). Ochratoxin A concentrations in food and feed from a region with Balkan endemic nephropathy. Food Addit Contam 19:755-764.
3. Apostolou E, El-Nezami HS, Ahokas JT, Donohue DC. (1998). The evaluation of ochratoxin A in human milk in Victoria (Australia). Rev Méd Vét 149:709-711.
4. Aslam M, Beg AE, Blaszkewicz M, Degen GH, Golka K. (2005). Ochratoxin A blood concentration in healthy subjects and bladder cancer cases from Pakistan. Mycot Res 21:164-167.
5. Assaf H, Betbeder A-M, Creppy EE, Pallardy M, Azouri H. (2004). Ochratoxin A levels in human plasma and foods in Lebanon. Hum Exp Toxicol 23:495-501. (Pubitemid 39472916)
6. Bacha H, Maarouf K, Achour A, Hamammi M, Ellouz F, Creppy EE. (1993). Ochratoxines et ochratoxicoses humaines en Tunisie. In: Creppy E, Castegnaro M, Dirheimer G, eds. Human Ochratoxicosis and Its Pathologies. Volume 231. Paris: John Libbey Eurotext, 123-127.
7. Bacha H, Maarouf K, Ghedira-Chekir L, Abid S, Cherif A, Achour A, Creppy EE. (1999). Mycotoxins and mycotoxicosis in Tunisia: What do we know and what do we need to know? J Toxicol Toxin Rev 18:245-262. (Pubitemid 29496000)
8. Biasucci G, Calabrese G, Di Giuseppe R, Carrara G, Colombo F, Mandelli B, Maj M, Bertuzzi T, Pietri A, Rossi F. (In press). The presence of ochratoxin A in cord serum and in human milk and its correspondence with maternal dietary habits. Eur J Nutr DOI 10.1007/s00394-010-0130-y.
9. Biró K, Barna-Vetró I, Pécsi T, Szabó E, Winkler G, Fink-Gremmels J, Solti L. (2003). Evaluation of spermatological parameters in ochratoxin A-challenged boars. Teriogenology 60:199-207. (Pubitemid 36737914)
10. Breitholtz A, Olsen M, Dahlbäck Å, Hult K. (1991). Plasma ochratoxin A levels in three Swedish populations surveyed using an ion-pair HPLC technique. Food Addit Contam 8:183-192.
11. Breitholtz-Emanuelsson A, Olsen M, Oskarsson A, Palminger I, Hult K. (1993a). Ochratoxin A in cow's milk and in human milk with corresponding human blood samples. JAOAC Int 76:842-846.
12. Breitholtz-Emanuelsson A, Minervini F, Hult K, Visconti A. (1994). Ochratoxin A in human serum samples collected in southern Italy from healthy individuals and individuals sufering from diferent kidney disorders. Nat Toxins 2:366-370.
13. Breitholtz-Emanuelsson A, Palminger-Hallen I, Wohlin PO, Oskarsson A, Hult K, Olsen M. (1993b). Transfer of ochratoxin A from lactating rats to their ofspring: A short-term study. Nat Toxins 1:347-352. (Pubitemid 23295662)
14. Bunge I, Dirheimer G, Röschenthaler R. (1978). In vivo in vitro inhibition of protein synthesis in Bacillus stearothermophilus by ochratoxin A. Biochem Biophys Res Commun 83:398-405. (Pubitemid 8391839)
15. Castegnaro M, Canadas D, Vrabcheva T, Petkova-Bocharova T, Chernozemsky IN, Pfohl-Leszkowicz A. (2006). Balkan endemic nephropathy: Role of ochratoxins A through biomarkers. Mol Nutr Food Res 50:519-529. (Pubitemid 43944161)
16. Castegnaro M, Maru V, Maru G, Ruiz-Lopez MD. (1990). High performance liquid chromatography determination of ochratoxin A and its 4R-4-hydroxy metabolite in human urine. Analyst 115:129-131. (Pubitemid 20122324)
17. Conseil Supérieur d'Hygiène Publique de France. (1999). Les mycotoxines dans l'alimentation: évaluation et gestion du risqué. Paris, France: Lavoisier, Tec & Doc.
18. Coronel MB, Sanchis V, Ramos AJ, Marin S. (2009). Assessment of the exposure to ochratoxin A in the province of Lleida, Spain. Food Chem Toxicol 47:2847-2852.
19. Creppy EE, Baudrimont I, Betbeder A-M. (1995). Prevention of nephrotoxicity of ochratoxin A, a food contaminant. Toxicol Lett 82-83:869-877. (Pubitemid 26057537)
20. Creppy EE, Betbeder AM, Gharbi A, Counord J, Castegnaro M, Bartsch H, Moncharmont P, Fouillet B, Chambon P, Dirheimer G. (1991). Human ochratoxicosis in France. IARC Sci Publ (115):145-151.
21. Curtui VG, Gareis M. (2001). A simple HPLC method for the determination of the mycotoxins ochratoxin A and B in blood serum of swine. Food Addit Contam 18:635-643. (Pubitemid 32685157)
22. Dahlmann A, Dantzler WH, Silbernagl S, Gekle M. (1998). Detailed mapping of ochratoxin A reabsorption along the rat nephron in vivo: The nephrotoxin can be reabsorbed in all nephron segments by diferent mechanisms. J Pharmacol Exp Ter:286:157-162. (Pubitemid 28317987)
23. Dai J, Wright MW, Manderville RA. (2003). Ochratoxin A forms a carbon-bonded C8-deoxyguanosine nucleoside adduct: Implications for C8 reactivity by a phenolic radical. J Am Chem Soc 125:3716-3717. (Pubitemid 36512356)
24. Delatour T, Mally A, Richoz J, Özden S, Dekant W, Ihmels H, Otto D, Gasparutto D, Marin-Kuan M, Schilter B, Cavin C. (2008). Absence of 29-deoxyguanosine-carbon 8-bound ochratoxin A adduct in rat kidney DNA monitored by isotope dilution LC-MS/MS. Mol Nutr Food Res 52:472-482.
25. Dimitrov P, Tsolova S, Georgieva R, Bozhilova D, Simeonov V, Bonev A, Karmaus W. (2006). Clinical markers in adult ofspring of families with and without Balkan endemic nephropathy. Kidney Int 69:723-729. (Pubitemid 43237642)
26. Dinis AMP, Lino CM, Pena AS. (2007). Ochratoxin A in nephropathic patients from two cities of central zone in Portugal. J Pharm Biomed Anal 44:553-557. (Pubitemid 46880081)
27. Doerr JA, Huf WE, Tung HT, Wyatt RD, Hamilton PB. (1974). A survey of T-2 toxin, ochratoxin, and afatoxin for their efects on the coagulation of blood in young broiler chickens. Poult Sci 53:1728-1734.
28. Domijan AM, Peraica M, Fuchs R, Lucie A, Radi B, Balija M, Bosanac I, Grgievi D. (1999). Ochratoxin A in blood of healthy population in Zagreb. Arh hig Rada Toksikol 50:263-271. (Pubitemid 30010056)
29. Domijan A-M, Peraica M, Markov K, Fuchs R. (2009). Urine Ochratoxin A and Sphinganine/Sphingosine ratio in residents of the endemic nephropathy area in Croatia. Arh Hig Rada Toksikol 60:387-393.
30. Dostal A, Jakusova L, Cajdova J, Hudeckova H. (2008). Results of the frst studies of occurrence of Ochratoxin A in human milk in Slovakia. Bratisl Lek Listy 109:276-278.
31. Duarte S, Bento J, Pena A, Lino CM, Delerue-Matos C, Oliva-Teles T, Morais S, Correia M, Oliveira MBPP, Alves MR, Pereira JA. (2010). Monitoring of ochratoxin A exposure of the Portuguese population through a nationwide urine survey-Winter 2007. Sci Tot Environ 408:1195-1198.
32. Duarte SC, Bento JMV, Pena A, Lino CM. (2009a). Ochratoxin A exposure assessment of the inhabitants of Lisbon during winter 2007/2008 through bread and urine analysis. Food Addit Contam 26:1411-1420.
33. Duarte SC, Pena A, Lino CM. (2009b). Ochratoxin A non-conventional exposure sources-A review. Microchem J 93:115-120.
34. EFSA. (2006). Question no. EFSA.Q-2005-154. Opinion of the scientifc panel on contaminants in the food chain on a request from the commission related to ochratoxin A in food. EFSA.J 365:1-56.
35. El-Sayed AA, Neamat-Allah AA, Soher EA. (2000). Situation of mycotoxins in milk, dairy products and human milk in Egypt. Mycot Res 16:91-100.
36. EI-Sayed AA, Soher EA, Neamat-Allah AA. (2002). Human exposure to mycotoxins in Egypt. Mycot Res 18:23-30.
37. Erkekolu P, Sabuncuolu S, Aydn S, Fjahin G, Giray B. (2010). Determination of seasonal variations in serum ochratoxin A levels in healthy population living in some regions of Turkey by enzyme-linked immunosorbent assay. Toxicon 55:507-513.
38. Faucet V, Pfohl-Leszkowicz A, Dai J, Castegnaro M, Manderville RA (2004). Evidence for covalent DNA adduction by ochratoxin A following chronic exposure to rat and subacute exposure to pig. Chem Res Toxicol 17:1289-1296. (Pubitemid 39265886)
39. Fazecas B, Tar A, Kovacs M. (2005). Ochratoxin a content of urine samples of healthy humans in Hungary. Acta Vet Hung 53:35-44. (Pubitemid 40312606)
40. Fenske M, Fink-Gremmels J. (1990). Efects of fungal metabolites on testosterone secretion in vitro. Arch Toxicol 64:72-75. (Pubitemid 20011056)
41. Ferrufno-Guardia E V, Tangni EK, Larondelle Y, Ponchaut S. (2000). Transfer of ochratoxin A during lactation: Exposure of suckling via the milk of rabbit does fed a naturally contaminated Feed. Food Addit Contam 17:167-175. (Pubitemid 30160634)
42. Filali A, Betbeder AM, Baudrimont I, Benayada A, Soulaymani R, Creppy EE. (2002). Ochratoxin A in human plasma in Morocco: A preliminary survey. Hum Exp Toxicol 21:241-245. (Pubitemid 34785024)
43. Fink-Gremmels J. (2008). Mycotoxins in cattle feeds and carry-over to dairy milk: A review. Food Addit Contam Part A 25:172-180. (Pubitemid 351279945)
44. Galtier P, Baradat C, Alvinere M. (1977). Etude de l'élimination d'ochratoxine A par le lait chez la lapine. Ann Rech Vét 7:97-98.
45. Galvano F, Pietri A, Bertuzzi T, Gagliardi L, Ciotti S, Luisi S, Bognanno M, Fauci1 L, Iacopino AM, Nigro F, Volti GL, Vanella L, Giammanco G, Tina GL, Gazzolo D. (2008). Maternal dietary habits and mycotoxin occurrence in human mature milk. Mol Nutr Food Res 52:496-501.
46. García-Fonseca S, Ballesteros-Gómez A, Rubio S, Pérez-Bendito D. (2008). Coacervative extraction of Ochratoxin A in wines prior to liquid chromatography/fuorescence determination. Anal Chim Acta 617:3-10 (Pubitemid 351681888)
47. Gautier J-C, Richoz J, Welti DH, Markovic J, Gremaud E, Guengerich FP, Turesky RJ. (2001). Metabolism of ochratoxin A: Absence of formation of genotoxic derivatives by human and rat enzymes. Chem Res Toxicol 14:34-45. (Pubitemid 32064373)
48. Gekle M, Sauvant C, Schwerdt G. (2005). Ochratoxin A at nanomolar concentrations: A signal modulator in renal cells. Mol Nutr Food Res 49:118-130. (Pubitemid 40379811)
49. Ghali R, Hmaissia-Khlifa K, Mezigh CH, Ghorbel H, Maarouf K, Maschgoul S, Hedilli A. (2008). HPLC Determination of ochratoxin A in a low volume of human blood serum. Anal Lett 41:757-766. (Pubitemid 351499515)
50. Gharbi A, Trillon O, Betbeder AM, Counord J, Gauret MF, Pfohl-Leszkowicz A, Dirheimer G, Creppy EE. (1993). Some efects of ochratoxin A, a mycotoxin contaminating feeds and food, on rat testis. Toxicology 83:9-18.
51. Gilbert J, Brereton P, MacDonald S. (2001). Assessment of dietary exposure to ochratoxin A in the UK using a duplicate diet approach and analysis of urine and plasma samples. Food Addit Contam 18:1088-1093. (Pubitemid 33107598)
52. Grosse Y, Baudrimont I, Castegnaro M, Creppy EE, Dirheimer G, Pfohl-Leskowicz A. (1995). Ochratoxin A metabolites and DNA-adducts formation in monkey kidney cell. Chem Biol Interact 95:175-187.
53. Grosse Y, Chekir-Ghedira L Huc A, Obrecht-Pfumio S, Dirheimer G, Bacha H, Pfohl-Leskowicz A. (1997). Retinol ascorbic acid and alpha-tocopherol prevent DNA adduct formation in mice treated with the mycotoxin ochartoxin A and zearalenone. Cancer Lett 114:225-229. (Pubitemid 27140119)
54. Grosso F, Saïd S, Mabrouk I, Fremy JM, Castegnaro M, Jemmali M, Dragacci S. (2003). New data on the occurrence of ochratoxin A in human sera from patients afected or not by renal diseases in Tunisia. Food Chem Toxicol 41:1133-1140. (Pubitemid 36782518)
55. Gross-Steinmeyer K, Weymann J, Hege HG, Metzler M. (2002). Metabolism and lack of DNA reactivity of the mycotoxin ochratoxin a in cultured rat and human primary hepatocytes. J Agric Food Chem 50:938-945. (Pubitemid 34163649)
56. Gürbay A, Girgin G, Sabuncuolu SA,ahin G, Yurdakök M, Yiit Tekinalp G. (2009). Ochratoxin A: Is it present in human breast milk samples obtained mothers from Ankara, Turkey. In: Abstracts of the 46th Congress of the European Societies of Toxicology; 13-16 September 2009; Dresden, Germany. Toxicol Lett 189(Supp 1):S57-S273.
57. Gupta M, Bandopadhyay S, Paul B, Majumder SK. (1979). Hematological changes produced in mice by ochratoxin A. Toxicology 14:95-98. (Pubitemid 10192885)
58. Hagelberg S, Hult K, Fuchs R. (1989). Toxicokinetics of ochratoxin A in several species and its plasma-binding properties. J Appl Toxicol 9:91-96. (Pubitemid 19108620)
59. Hall PW, Vasiljevi M. (1973). Beta2-microglobulin excretion as an index of renal tubular disorders with special reference to endemic Balkan nephropathy. J Lab Clin Med 81:897-904.
60. Hassan AM, Sheashaa HA, Fattah MFA, Ibrahim AZ, Gaber OA, Sobh MA. (2006). Study of ochratoxin A as an environmental risk that causes renal injury in breast-fed Egyptian infants. Pediatr Nephrol 21:102-105. (Pubitemid 43040202)
61. Hassen W, Abid S, Achour A, Creppy E, Bacha H. (2004). Ochratoxin A and R-microglobulinuria in healthy individuals and in chronic interstitial nephropathy patients in the Centre of Tunisia: A hot spot of Ochratoxin A exposure. Toxicology 199:185-193. (Pubitemid 38624529)
62. Höhler D, Sudekum KH, Wolfram S, Frohlich AA, Marquardt RR. (1999). Metabolism and excretion of ochratoxin A fed to sheep. J Anim Sci 77:1217-1223. (Pubitemid 129552261)
63. Hult K, Plestina R, Habazin-Novak V, Radic B, Ceovic S. (1982). Ochratoxin A in human blood and Balkan endemic nephropathy. Arch Toxicol 51:313-321. (Pubitemid 13196429)
64. IARC. (1993). Some Naturally Occurring Substances, Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins. Monograph no. 56. Lyon, France: IARC.
65. Iavicoli I, Brera C, Carelli G, Caputi R, Marinaccio A, Miraglia M. (2002). External and internal dose in subjects occupationally exposed to ochratoxin A. Int Arch Occup Environ Health 75: 381-386. (Pubitemid 36075128)
66. JECFA. (1991). Evaluation of Certain Food Additives and Contaminants. Tirty-seventh report of the Joint FAO/WHO Expert Committee on Food Additives. WHO Technical Report Series, No. 806. Geneva: Joint FAO/WHO Expert Committee on Food Additives
67. JECFA (2001). Safety Evaluation of Certain Mycotoxins in Food. WHO Food Additives Series 47; FAO Food and Nutrition Paper 74. Available at: http://www.inchem.org/documents/jecfa/jecmono/v47je01.htm. Accessed 10 August 2008.
68. JECFA. (2007). Safety Evaluations of Specifc Mycotoxins: Ochratoxin A. Prepared by the 56th Meeting of the Joint FAO/WHO Expert Committee on Food Additives, 6-15 February, Geneva.
69. JECFA. (2008). Safety Evaluation of Certain Mycotoxins in Food. WHO Food Additives Series 59. Available at: http://whqlibdoc.who.int/publications/2008/ 978924 1660594-eng.pdf. Accessed 18 November 2009.
70. Jennings-Gee JE, Tozlovanu M, Manderville R, Miller MS, Pfohl-Leszkowicz A, Schwartz GG. (2010). Ochratoxin A: In utero exposure in mice induces adducts in testicular DNA. Toxins 2:1428-1444.
71. Jiménez AM, Lopez de Cerain" A, Gonzalez-Peñas E, Bello J, Betbeder AM, Creppy EE. (1998). Exposure to ochratoxin A in Europe: Comparison with a region of northern Spain. Toxin Rev 17:479-491. (Pubitemid 29015377)
72. Jonsyn FE, Maxwell SM, Hendrickse RG. (1995). Ochratoxin A and afatoxins in breast milk samples from Sierra Leone. Mycopathology 131:121-126. (Pubitemid 3009812)
73. Jonsyn FE. (1999). Intake of afatoxins and ochratoxins by infants in Sierra Leone: Possible efects on the general health of these children. J Nutr Environ Med 9:15-22. (Pubitemid 29141964)
74. Jonsyn-Ellis FE. (2000). Seasonal variation in exposure frequency and concentration levels of afatoxins and ochratoxins in urine samples of boys and girls. Mycopathology 152:35-40. (Pubitemid 32984105)
75. Jonsyn-Ellis FE. (2007). Afatoxins and ochratoxins in serum samples of school children. J Nutr Environ Med 16:52-58. (Pubitemid 47400406)
76. Jørgensen K, Petersen A. (2002). Content of ochratoxin A in paired kidney and meat samples from healthy Danish slaughter pigs. Food Addit Contam 19:562-567. (Pubitemid 34746276)
77. Karima H-K, Ridha G, Zied A, Chekib M, Salem M, Abderrazek H. (2010). Estimation of Ochratoxin A in human blood of healthy Tunisian population. Exp Toxicol Pathol 62:539-542.
78. Khalef A, Zidane C, Charef A, Gharbi A, Tadjerouna M, Betbeder AM, Creppy EE. (1993). Ochratoxicoses humaines en Algérie. In: Creppy E, Castegnaro M, Dirheimer G, eds. Human Ochratoxicosis and Its Pathologies. Volume 231. Paris: John Libbey Eurotext, 123-127.
79. Kovács F, Sándor G, Ványi A, Domány S, Zomborszky-Kovács M. (1995). Detection of ochratoxin A in human blood and colostrum. Acta Vet Hung 43:393-400
80. Krogh P, Hald B, Plestina R, Ceovi S. (1977). Balkan (endemic) nephropathy and foodborne Ochratoxin A: Preliminary results of a survey of foodstufs. Acta Pathol Microbiol Scand B 85, 238-240. (Pubitemid 8138802)
81. Krogh P. (1977). Ochratoxin A residues in tissues of slaughter pigs with nephropathy. Nord Vet Med 29:402-405. (Pubitemid 8178322)
82. Kuiper-Goodman T, Hilts C, Billiard SM, Kiparissis Y, Richard IDK, Hayward S. (2010). Health risk assessment of ochratoxin A for all age-sex strata in a market Economy. Food Addit Contam 27, 212-240.
83. Kuiper-Goodman T. (1990). Uncertainties in the risk assessment of three mycotoxins: Afatoxin, ochratoxin, and zearalenone. Can J Physiol Pharmacol 68:1017-1024. (Pubitemid 20242631)
84. Kyrtopoulos SA. (2006). Biomarkers in environmental carcinogenesis research: Striving for a new momentum. Toxicol Lett 162:3-15. (Pubitemid 43243153)
85. Larsen JC. (1995). Levels of pollutants and their metabolites: Exposures to organic substances. Toxicology 101:11-27.
86. Li S, Marquardt RR, Frohlich AA. (2000). Identifcation of ochratoxins and some of their metabolites in bile and urine of rats. Food Chem Toxicol 38:141-152. (Pubitemid 30136265)
87. Lino CM, Baeta ML, Henri M, Dinis AMP, Pena AS, Silveira MIN. (2008). Levels of ochratoxin A in serum from urban and rural Portuguese populations and estimation of exposure degree. Food Chem Toxicol 46:879-885. (Pubitemid 351172560)
88. Maarouf K, Achour A, Hamammi M, El May M, Betbeder AM, Ellouz F, Creppy EE, Bacha H. (1995). Ochratoxin A in human blood in relation to nephropathy in Tunisia. Hum Exp Toxicol 14:609-615.
89. MAFF-Ministry of Agriculture, Fisheries and Food. (April 1999). A Survey of Human Exposure to Ochratoxin A. Food Surveillance Information Sheet, number 172. London, United Kingdom.
90. Mally A, Dekant W. (2009). Mycotoxins and the kidney: Modes of action for renal tumor formation by ochratoxin A in rodents. Mol Nutr Food Res 53:467-478.
91. Mally A, Hard GC, Dekant W. (2007). Ochratoxin A as a potential etiologic factor in endemic nephropathy: Lessons learned from toxicity studies in rats. Food Chem Toxicol 45:254-2260.
92. Mally A, Zepnik H, Wanek P, Eder E, Dingley K, Ihmels H, Völkel W, Dekant W. (2004). Ochratoxin A: Lack of formation of covalent DNA adducts. Chem Res Toxicol 17:234-242. (Pubitemid 38252503)
93. Manderville RA, Pfohl-Leszkowicz A. (2008). Bioactivation and DNA adduction as a rationale for ochratoxin A carcinogenesis. World Mycot J 1:357-367.
94. Manique R, Pena A, Lino CM, Moltó JC, Mañez J. (2008). OchratoxinA in themorning and afternoon portions of urine from Coimbra and Valencia populations. Toxicon 51:1281-1287.
95. Mantle PG, Faucet-Marquis V, Manderville RA, Sciqualli B, Pfohl-Leszkowicz A. (2010). Structures of covalent adducts between DNA and ochratoxin A: A new factor in debate about genotoxicity and human risk assessment. Chem Res Toxicol 23:89-98.
96. Micco C, Ambruzzi A, Miraglia M, Brera C, Onori R, Benelli L. (1991). Contamination of human milk with ochratoxin A. In: Castegnaro PR, Plestina R, Dirheimer M, Chernozemsky G, Bartsch IN, eds. Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours. Lyon, France: IARC, 105-108.
97. Micco C, Miraglia M, Brera C, Corneli S, Ambruzzi A. (1995). Evaluation of ochratoxin A level in human milk in Italy. Food Addit Contam Part A 12:351-354.
98. Miraglia M, Brera C, Colatosti M. (1996). Application of Biomarkers to assessment of risk to human health from exposure to mycotoxins. Microchem J 54:472-477. (Pubitemid 126346906)
99. Miraglia M, Brera C. (2002). Assessment of dietary intake of ochratoxin A by the population of EU member states. SCOOP/2002. Task 3.2.7. Brussels: European Union.
100. Mosesso P, Cinelli S, Piñerro J, Bellacima R, Pepe G. (2008). In vitro cytogenetic results supporting a DNA nonreactive mechanism for ochratoxin A, potentially relevant for its carcinogenicity. Chem Res Toxicol 21:1235-1243. (Pubitemid 351967388)
101. Muñoz K, Blaszkewicz M, Degen G. (In press). Simultaneous analysis of ochratoxin A and its major metabolite ochratoxin alpha in plasma and urine for an advanced biomonitoring of the mycotoxin. J Chromatogr B 2010.878.2623-2629.
102. Muñoz K, Vega M, Rios G, Muñoz S, Madariaga R. (2006). Preliminary study of Ochratoxin A in human plasma in agricultural zones of Chile and its relation to food consumption. Food Chem Toxicol 44:1884-1889. (Pubitemid 44894148)
103. Navas SA, Sabino M, Rodriguez-Amaya DB. (2005). Afatoxin M1 and ochratoxin A in a human milk bank in the city of São Paulo, Brazil. Food Addit Contam 22:457-462. (Pubitemid 40872890)
104. Nikolov IG, Chernozemsky IN, Petkova-Bocharova T, Vrabcheva T, Stojchev I, Bankov B, Castegnaro M, Pfohl-Leszkowicz A, Dragacci S, Day N, Gill C, Useleber E, Dietrich R, Martlbauer E. (2002). Review of the cooperative studies of the national oncological centre in Bulgaria on Balkan endemic nephropathy and associated urinary tract tumours (1991-2001). Facta Univ Ser Med Biol 9:119-122.
105. Nordic Working Group on Food Toxicology and Risk Evaluation. (1991). Health Evaluation of ochratoxin A in food products. Nordic Seminar and Work Report 545. Copenhagen, Denmark: Nordic Council of Ministers, 1-26.
106. Obrecht-Pfumio S, Dirheimer G. (2000). In vitro DNA and dGMP adducts formation caused by ochratoxin A. Chem Biol Interact 127:29-44. (Pubitemid 30618730)
107. Ostry V, Malir F, Roubal T, Skarkova J, Ruprich J, Cerna M, Creppy EE. (2005). Monitoring of mycotoxin biomarkers in the Czech Republic. Mycot Res 21:49-52.
108. Özçelik N, Ko§ar A, Soysal D. (2001). Ochratoxin A in human serum samples collected in Isparta-Turkey from healthy individuals and individuals sufering from diferent urinary disorders. Toxicol Lett 121:9-13. (Pubitemid 32324120)
109. Pacin AM, Ciancio Bovier EV, Motta E, Resnik SL, Villa D, Olsen M. (2008). Survey of Argentinean human plasma for ochratoxin A. Food Addit Contam Part A 25:635-641. (Pubitemid 351910966)
110. Palli D, Miraglia M, Saieva C, Masala G, Cava E, Colatosti M, Corsi AM, Russo A, Brera C. (1999). Serum levels of Ochratoxin A in healthy adults in Tuscany: Correlation with individual characteristics and between repeat measurements. Cancer Epidemiol Biomark Prevent 8:265-269. (Pubitemid 29114205)
111. Pascale M, Visconti A. (2000). Rapid method for the determination of ochratoxin A in urine by immunoafnity column clean-up and high-performance liquid chromatography. Mycopathology 152:91-95.
112. Pena A, Seifrtová M, Lino CM, Silveira MIN, Solich P. (2006). Estimation of ochratoxin A in Portuguese population: New data on the occurrence in human urine by high performance liquid chromatography with fuorescence detection. Food Chem Toxicol 4:1449-1454. (Pubitemid 43994285)
113. Peraica M, Domijan A-M, Fuchs R, Lucie A, Radi B. (1999). The occurrence of ochratoxin A in blood in general population of Croatia. Toxicol Lett 110:105-112. (Pubitemid 29502433)
114. Peraica M, Domijan AM, Matasin M, Lucie A, Radi B, Delas F, Horvat M, Bosanac I, Balija M, Grgievi D. (2001). Variations of ochratoxin A concentrations in the blood of healthy populations in some Croatian cities. Arch Toxicol 75:410-414. (Pubitemid 32905558)
115. Petkova-Bocharova T, Castegnaro M. (1985). Ochratoxin A contamination of cereal in an area of high incidence of Balkan endemic nephropathy in Bulgaria. Food Addit Contam 2:267-270. (Pubitemid 16256411)
116. Petkova-Bocharova T, Castegnaro M, Pfohl-Leszkowicz A, Garren L, Grosso F, Nikolov I, Vrabcheva T, Dragacci S, Chernozemsky IN. (2003). Analysis of ochratoxin A in serum and urine of inhabitants from an area with Balkan endemic nephropathy: A one month follow up study. Facta Univ Ser Med Biol 10:62-68.
117. Petkova-Bocharova T, Chernozemsky IN, Castegnaro M. (1988). Ochratoxin A in human blood in relation to Balkan endemic nephropathy and urinary system tumours in Bulgaria. Food Addit Contam 5:299-301.
118. Pfohl-Leszkowicz A, Grosse Y, Kane A, Creppy EE, Dirheimer G. (1993). Diferential DNA adduct formation and disappearance in the mouse tissues after treatment with the mycotoxin ochratoxin A. Mutat Res 289:265-273. (Pubitemid 23287937)
119. Pfohl-Leszkowicz A. (2009). Ochratoxin A and aristolochic acid involvement in nephropathies and associated urothelial tract tumours. Arh Hig Rada Toksikol 60:465-483.
120. Pfohl-Leszkowicz A, Manderville RA. (2007). Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans. Mol Nutr Food Res 51:61-99. (Pubitemid 46144764)
121. Pfohl-Leszkowicz A, Petkova-Bocharova T, Chernozemsky IN, Castegnaro M. (2002). Balkan endemic nephropathy and associated urinary tract tumours: A review on aetiological causes and the potential role of mycotoxins. Food Addit Contam 19:282-302. (Pubitemid 34121385)
122. Pfohl-Leszkowicz A, Pinelli E, Bartsch H, Mohr U, Castegnaro M. (1998). Sex- and strain-specifc expression of cytochrome P450s in ochratoxin A-induced genotoxicity and carcinogenicity in rats. Mol carcinog 23:76-85. (Pubitemid 28507417)
123. Pfohl-Leszkowicz A, Tozlovanu M, Manderville R, Peraica M, Castegnaro M, Stefanovic V. (2007). New molecular and feld evidences for the implication of mycotoxins but not aristolochic acid in human nephropathy and urinary tract tumor. Mol Nutr Food Res 51:1131-1146. (Pubitemid 47522807)
124. Poirier MC, Santella RM, Weston A. (2000). Carcinogen macromolecular adducts and their measurement. Carcinogenesis 21:353-359. (Pubitemid 30137920)
125. Postupolski J, Karłowski K, Kubik P. (2006). Ochratoxin a in maternal and foetal blood and in maternal milk. Rocz Panstw Zakl Hig 57:23-30.
126. Radi B, Fuchs R, Peraica M, Luci A. (1997). Ochratoxin A in human sera in the area with endemic nephropathy in Croatia. Toxicol Lett 91:105-109. (Pubitemid 27214561)
127. Rizzo A, Eskola M, Atroshi F. (2002). Ochratoxin A in cereals, foodstufs and human plasma. Eur J Plant Pathol 108:631-637. (Pubitemid 35293884)
128. Roth A, Chakor K, Creepy EE, Kane A, Roschenthaler R, Dirheimer G. (1988). Evidence for an enterohepatic circulation of ochratoxin A in mice. Toxicology 48:293-308. (Pubitemid 18045574)
129. Saboli I, Asif AR, Budach WE, Wanke C, Bahn A, Burckhardt G. (2007). Gender diferences in kidney function. Pfugers Arch Eur J Physiol 455: 397-429.
130. Sangare-Tigori B, Moukha S, Kouadio JH, Dano DS, Betbeder A-M, Achour A, Creppy EE. (2006). Ochratoxin A in human blood in Abidjan, Côte d'Ivoire. Toxicon 47:894-900. (Pubitemid 43849895)
131. Sauvant C, Holzinger H, Gekle M. (2005). Proximal tubular toxicity of ochratoxin A is amplifed by simultaneous inhibition of the extracellular signal-regulated kinases 1/2. J Pharmacol Exp Ter 313:234-241. (Pubitemid 40411347)
132. SCF-Scientifc Committee on Food. (1998). EC report, Opinion on ochratoxin A, expressed on 17 September 1998. Health and Consumers Directorate-General. Brussels, Belgium.
133. Schlatter C, Studer RJ, Rasonyi T. (1996). Carcinogenicity and kinetic aspects of ochratoxin A. Food Addit Contam 43-44. (Pubitemid 27011139)
134. Schwartz GG. (2002). Hypothesis: Does ochratoxin A cause testicular cancer? Cancer Causes Cont 13:91-100. (Pubitemid 34163955)
135. Schwerdt G, Freudinger R, Silbernagl S, Gekle M. (1999). Ochratoxin A-binding proteins in rat organs and plasma and diferent cell lines of the kidney. Toxicology 135:1-10. (Pubitemid 29295444)
136. Schwerdt G, Holzinger H, Königs M, Humpf H-U, Gekle M. (2009). Efect of ochratoxin A on cell survival and collagen homeostasis in human mesangial cells in primary culture. Food Chem Toxicol 47:209-213.
137. Scott PM. (2005). Biomarkers of human exposure to ochratoxin A. Food Addit Contam 22(Supp 1):99-107. (Pubitemid 44574579)
138. Shephard GS, Van der Westhuizen L, Sewram V. (2007). Biomarkers of exposure to fumonisin mycotoxins: A review. Food Addit Contam 24:1196-1201. (Pubitemid 47471159)
139. Skaug MA, Helland I, Solvoll K, Saugstad OD. (2001). Presence of ochratoxin A in human milk in relation to dietary intake. Food Addit Contam 18:321-327. (Pubitemid 32366735)
140. Skaug MA, Størmer FC, Saugstad OD. (1998). Ochratoxin A: A naturally occurring mycotoxin found in human milk samples from Norway. Acta Pædiatr 87:1275-1278. (Pubitemid 29001887)
141. Solti L, Pécsi T, Barna-Vetró I, Szász F, Biró K, Szabó E. (1999). Analysis of serum and seminal plasma after feeding ochratoxin A with breeding boars. Anim Reprod Sci 56:123-132. (Pubitemid 29360574)
142. Stefanovic V, Cukuranovic R, Mitic-Zlatkovic M, Hall PW. (2002). Increased urinary albumin excretion in children from families with Balkan nephropathy. Pediatr Nephrol 17:913-916. (Pubitemid 36097390)
143. Stefanovic V, Mitic-Zlatkovic M, Cukuranovic R, Miljkovic P, Pavlovic NM, Vlahovic P. (1991). β2-microglobulin in patients with Balkan nephropathy and in healthy members of their families. Kidney Int 40:21-26.
144. Stefanovic V, Mitic-Zlatkovic M, Cukuranovic R, Vlahovic P. (2003). Increased urinary protein excretion in children from families with Balkan endemic nephropathy. Nephron Clin Pract 95:116-120.
145. Stoev SD. (2010). Studies on carcinogenic and toxic efects of ochratoxin A in chicks. Toxins 2:649-664.
146. Stoev SD, Vitanov S, Anguelov G, Petkova-Bocharova T, Creppy EE. (2001). Experimental mycotoxic nephropathy in pigs provoked by a diet containing ochratoxin A and penicillic acid. Vet Res Com 25:205-223.
147. Stojkovic R, Hult S, Gamulin R, Plestina R. (1984). High afnity binding of ochratoxin A to plasma constituents. Biochem Int 9:33-38. (Pubitemid 14061115)
148. Studer-Rohr I, Schlatter J, Dietrich DR. (2000). Kinetic parameters and intraindividual fuctuations of ochratoxin A plasma levels in humans. Arch Toxicol 74:499-510.
149. Suzuki S, Satoh T, Yamazaki M. (1975). Efect of ochratoxin A on carbohydrate metabolism in rat liver. Toxicol Appl Pharmacol 32:116-122.
150. Tuvander A, Paulsen JE, Axberg K, Johansson N, Vidnes A, Enghardt-Barbieri H, Trygg K, Lund-Larsen K, Jahrl S, Widenfalk A, Bosnes V, Alexander J, Hult K, Olsen M. (2001). Levels of ochratoxin A in blood from Norwegian and Swedish blood donors and their possible correlation with food consumption. Food Chem Toxicol 39:1145-1151. (Pubitemid 33030227)
151. Timbrell JA. (1998). Biomarkers in toxicology. Toxicology 129:1-12. (Pubitemid 29084427)
152. Tozlovanu M, Faucet-Marquis V, Pfohl-Leszkowicz A, Manderville RA (2006). Genotoxicity of the hydroquinone metabolite of ochratoxin A: Structure-activity relationships for covalent DNA adduction. Chem Res Toxicol 19:1241-1247. (Pubitemid 44454042)
153. Turconi G, Guarcello M, Livieri C, Comizzoli S, Maccarini L, Castellazzi AM, Pietri A, Piva G, Roggi C. (2004). Evaluation of xenobiotics in human milk and ingestion by the newborn-An epidemiological survey in Lombardy (Northern Italy). Eur J Nutr 43:191-197. (Pubitemid 39222531)
154. Ueno Y, Maki S, Lin J, Furuya M, Sugiura Y, Kawamura O. (1998). A 4-year study of plasma ochratoxin a in a selected population in Tokyo by immunoassay and immunoafnity column-linked HPLC. Food Chem Toxicol 36:445-449. (Pubitemid 28267374)
155. Vaidya VS, Ferguson MA, Bonventre JV. (2008). Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol 48:463-493. (Pubitemid 351738161)
156. Valenta H. (1998). Chromatographic methods for the determination of ochratoxin A in animal and human tissues and fuids. J Chromatogr A 815:75-92. (Pubitemid 28342720)
157. Van der Merwe KJ, Steyn PS, Fourie L, Scott DB, Teron JJ. (1965). Ochratoxin A, a toxic metabolite produced by Aspergillus ochraceus Wilh. Nature 205:1112-1113.
158. Vatinno R, Aresta A, Zambonin CG, Palmisano F. (2007). Determination of ochratoxin A in human urine by solid-phase microextraction coupled with liquid chromatography-fuorescence detection. J Pharm Biomed Anal 44:1014-1018. (Pubitemid 47095197)
159. Wafa EW, Yahya RS, Sobh MA, Eraky I, El-Baz M, El-Gayar HAM, Betbeder AM, Creppy EE. (1998). Human ochratoxicosis and nephropathy in Egypt: A preliminary study. Hum Exp Toxicol 17:124-129. (Pubitemid 28076003)
160. Zimmerli B, Dick R. (1995). Determination of ochratoxin A at the ppt level in human blood, serum, milk and some foodstufs by high-performance liquid chromatography with enhanced fuorescence detection and immunoafnity column cleanup: Methodology and Swiss data. J Chromatogr B Biomed Appl 666:85-99.